Cite
CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin
MLA
Genovefa Kolovou, et al. “CYP3A5 Genotyping for Assessing the Efficacy of Treatment with Simvastatin and Atorvastatin.” Genetics and Molecular Biology, vol. 38, no. 2, June 2015, pp. 129–37. EBSCOhost, https://doi.org/10.1590/S1415-4757382220140239.
APA
Genovefa Kolovou, Vana Kolovou, Georgia Ragia, Constantinos Mihas, Olga Diakoumakou, Ioannis Vasiliadis, Sophie Mavrogeni, Vassiliki Vartela, & Vangelis G Manolopoulos. (2015). CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin. Genetics and Molecular Biology, 38(2), 129–137. https://doi.org/10.1590/S1415-4757382220140239
Chicago
Genovefa Kolovou, Vana Kolovou, Georgia Ragia, Constantinos Mihas, Olga Diakoumakou, Ioannis Vasiliadis, Sophie Mavrogeni, Vassiliki Vartela, and Vangelis G Manolopoulos. 2015. “CYP3A5 Genotyping for Assessing the Efficacy of Treatment with Simvastatin and Atorvastatin.” Genetics and Molecular Biology 38 (2): 129–37. doi:10.1590/S1415-4757382220140239.